These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38949885)

  • 61. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Parathyroid hormone during maintenance dialysis: influence of low calcium dialysate, plasma albumin and age.
    Heaf JG; Løkkegård H
    J Nephrol; 1998; 11(4):203-10. PubMed ID: 9702872
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dialysate calcium and the European best practice guidelines on hemodynamic instability.
    Kooman JP; Basci A; Pizzarelli F; Vanholder R;
    Semin Dial; 2009; 22(3):311. PubMed ID: 19573013
    [No Abstract]   [Full Text] [Related]  

  • 64. Calcium balance during hemodialysis.
    McIntyre CW
    Semin Dial; 2008; 21(1):38-42. PubMed ID: 18251956
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparison of Prescribed and Measured Dialysate Sodium: A Quality Improvement Project.
    Gul A; Miskulin DC; Paine SS; Narsipur SS; Arbeit LA; Harford AM; Weiner DE; Schrader R; Horowitz BL; Zager PG
    Am J Kidney Dis; 2016 Mar; 67(3):439-45. PubMed ID: 26776538
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A higher magnesium dialysate concentration treats hypomagnesemia.
    Eisenman K; Holley JL
    Perit Dial Int; 2005; 25(6):604-5. PubMed ID: 16411530
    [No Abstract]   [Full Text] [Related]  

  • 67. Removal of Cell-Activating Substances Using Dialyzers With Various Permeability Profiles.
    Latosinska A; Hulko M; Speidel R; Mischak H; Storr M; Krause B
    Artif Organs; 2018 Jan; 42(1):78-87. PubMed ID: 28744941
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The influence of dialysis time and dialyser reuse on survival.
    Shaldon S
    Nephrol Dial Transplant; 1995; 10 Suppl 3():57-62. PubMed ID: 7494617
    [No Abstract]   [Full Text] [Related]  

  • 69. Dialysis: Membrane flux, dialysate purity and cardiovascular outcomes.
    Grooteman M; Nubé M
    Nat Rev Nephrol; 2013 Aug; 9(8):439-41. PubMed ID: 23797202
    [No Abstract]   [Full Text] [Related]  

  • 70. Sodium flux during hemodialysis and hemodiafiltration treatment of acute kidney injury: Effects of dialysate and infusate sodium concentration at 140 and 145 mmol/L.
    Buzancais A; Brunot V; Larcher R; Tudesq JJ; Platon L; Besnard N; Amalric M; Daubin D; Corne P; Moulaire V; Jung B; Canaud B; Cristol JP; Klouche K
    Artif Organs; 2023 Jun; 47(6):999-1006. PubMed ID: 36527419
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A new approach to individualize dialysis fluid sodium concentration using a four-stream, bicarbonate-based fluid delivery system.
    Lew SQ; Cheng YL; Tzamaloukas AH; Ing TS
    Artif Organs; 2021 Jul; 45(7):779-783. PubMed ID: 33534933
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Fluid and hemodynamic management in hemodialysis patients: challenges and opportunities.
    Canaud B; Chazot C; Koomans J; Collins A
    J Bras Nefrol; 2019; 41(4):550-559. PubMed ID: 31661543
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Dialysate purity: a must.
    Ramírez R; Carracedo J; Martín-Malo A; Rodríguez M; Aljama P
    Contrib Nephrol; 2002; (137):325-31. PubMed ID: 12101973
    [No Abstract]   [Full Text] [Related]  

  • 74. A new method of post-dialysis blood urea sampling: the 'stop dialysate flow' method.
    Geddes CC; Traynor J; Walbaum D; Fox JG; Mactier RA
    Nephrol Dial Transplant; 2000 Apr; 15(4):517-23. PubMed ID: 10727547
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Direct measurement of nitric oxide concentration in CAPD dialysate.
    Mochizuki S; Takayama A; Sasaki T; Horike H; Kashihara N; Ogasawara Y; Kajiya F; Kitawaki T; Oka H
    Perit Dial Int; 2009; 29(1):111-4. PubMed ID: 19164261
    [No Abstract]   [Full Text] [Related]  

  • 76. Effect of dialysate sodium reduction on body water volume, blood pressure, and inflammatory markers in hemodialysis patients--a prospective randomized controlled study.
    Beduschi GC; Telini LS; Caramori JC; Martin LC; Barretti P
    Ren Fail; 2013; 35(5):742-7. PubMed ID: 23635012
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of Standard and Individualized Dialysate Sodium in Chronic Hemodialysis Patients Upon Echocardiography Parameters.
    Eftimovska-Otovikj N; Stojceva-Taneva O; Petkovikj N
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2022 Jul; 43(2):123-133. PubMed ID: 35843920
    [No Abstract]   [Full Text] [Related]  

  • 78. Recovery time, quality of life, and mortality in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Rayner HC; Zepel L; Fuller DS; Morgenstern H; Karaboyas A; Culleton BF; Mapes DL; Lopes AA; Gillespie BW; Hasegawa T; Saran R; Tentori F; Hecking M; Pisoni RL; Robinson BM
    Am J Kidney Dis; 2014 Jul; 64(1):86-94. PubMed ID: 24529994
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Leptin in peritoneal dialysate from continuous ambulatory peritoneal dialysis patients.
    Tsujimoto Y; Shoji T; Tabata T; Morita A; Emoto M; Nishizawa Y; Morii H
    Am J Kidney Dis; 1999 Nov; 34(5):832-8. PubMed ID: 10561138
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Elimination of NTproBNP in peritoneal dialysis patients. Does peritoneal membrane type make a difference in plasma level and elimination of NTproBNP?
    Koz S; Sahin I; Temel I; Koz ST; Terzi Z
    Clin Nephrol; 2016 May; 85(5):266-72. PubMed ID: 27007867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.